Evolving Treatment in Newly Diagnosed Multiple Myeloma Patients - Episode 1
Key Considerations and Patient Factors in Frontline Therapy Selection for Transplant-Ineligible NDMM Patients
Elizabeth O’Donnell, MD, discusses the key considerations when choosing frontline therapy for transplant-ineligible patients with newly diagnosed multiple myeloma and how factors such as frailty, age, and performance status influence the decision-making process.
Video Player is loading.
- Please comment on the key considerations when choosing frontline therapy for transplant-ineligible patients with newly diagnosed multiple myeloma.
- How do patient factors such as frailty, age, and performance status influence your decision-making process?
Related Content:
